[ad_1]
Rhythm Pharmaceuticals RYTM reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Rhythm Pharmaceuticals beat estimated earnings by 6.32%, reporting an EPS of $-0.89 versus an estimate of $-0.95.
Revenue was up $2.04 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 10.11% drop in the share price the next day.
Here’s a look at Rhythm Pharmaceuticals’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.01 | -0.91 | -0.81 | -0.71 |
| EPS Actual | -1.05 | -0.85 | -0.70 | -0.70 |
| Revenue Estimate | 2.30M | 1.70M | 930K | 550K |
| Revenue Actual | 1.50M | 1.82M | 1.03M | 274K |
To track all earnings releases for Rhythm Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.